Skip to main content
SpringerLink
Log in

Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction

  • Commentary
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, PARADIGM-HF Investigators and Committees, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004. https://doi.org/10.1056/NEJMoa1409077.

    Article  CAS  PubMed  Google Scholar 

  2. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, PARAGON-HF Investigators and Committees, et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381:1609–20. https://doi.org/10.1056/NEJMoa1908655.

    Article  CAS  PubMed  Google Scholar 

  3. Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, et al. B-type natriuretic peptide during treatment with sacubitril/valsartan: the PARADIGM-HF Trial. J Am Coll Cardiol. 2019;73:1264–72. https://doi.org/10.1016/j.jacc.2019.01.018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pericas P, Mas-Lladó C, Ramis-Barceló MF, Valadrón I, Noris Mora M, Pasamar Márquez L, et al. Impact of sacubitril-valsartan treatment on diastolic function in patients with heart failure and reduced ejection fraction. High Blood Press Cardiovasc Prev. 2021. https://doi.org/10.1007/s40292-021-00437-x.

    Article  PubMed  Google Scholar 

  5. Nordén ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, et al. Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload. ESC Heart Fail. 2021. https://doi.org/10.1002/ehf2.13177 (epub ahead of print).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Schauer A, Adams V, Augstein A, Jannasch A, Draskowski R, Kirchhoff V, et al. Sacubitril/valsartan improves diastolic function but not skeletal muscle function in a rat model of HFpEF. Int J Mol Sci. 2021;22:3570. https://doi.org/10.3390/ijms22073570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Martens P, Beliën H, Dupont M, Vandervoort P, Mullens W. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction. Cardiovasc Ther. 2018;36:e12435. https://doi.org/10.1111/1755-5922.12435.

    Article  CAS  PubMed  Google Scholar 

  8. Cosentino ER, Degli Esposti D, Miceli R, Bentivenga C, Landolfo M, Fg Cicero A, et al. Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction. Curr Med Res Opin. 2019;35:9–12. https://doi.org/10.1080/03007995.2019.1576481.

    Article  CAS  PubMed  Google Scholar 

  9. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277–314. https://doi.org/10.1016/j.echo.2016.01.011.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Unit of Internal Medicine and Hypertension Centre, Department of Clinical and Experimental Medicine, University of Catania, c/o Cannizzaro Hospital, Via Messina 829, 95126, Catania, Italy

    Agata Buonacera, Benedetta Stancanelli & Lorenzo Malatino

Authors
  1. Agata Buonacera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benedetta Stancanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorenzo Malatino
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Dr. AB wrote the paper. Prof. LM and Dr. BS debated data of the Literature and revised the manuscript for its intellectual content.

Corresponding author

Correspondence to Lorenzo Malatino.

Ethics declarations

Conflict of interest

The Authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buonacera, A., Stancanelli, B. & Malatino, L. Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction. High Blood Press Cardiovasc Prev 28, 331–332 (2021). https://doi.org/10.1007/s40292-021-00455-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40292-021-00455-9

Search

Navigation